Serine/threonine-specific protein kinase (Akt) activation generates the anti-apoptotic and anti-inflammatory responses in tumor cells, thereby protecting it from drug induced apoptosis or inflammatory apoptosis. This evidence concerns the gene DYRK1A and neoplasm.